How Wegovy and Mounjaro Compare for Weight Management
Wegovy vs Wegovy for weight management: Understanding the Key Differences
When comparing Wegovy vs Wegovy for weight management, the fundamental distinction lies in their licensed indications. Wegovy contains semaglutide and is specifically licensed by the MHRA for weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. Ozempic contains the same active ingredient but is licensed exclusively for type 2 diabetes treatment in the UK. Promoting Wegovy for weight management constitutes off-label use, which EverydayMeds does not support as a GPhC-registered pharmacy (#9012878).
The comparison between Wegovy and Mounjaro presents a more meaningful choice for weight management. Wegovy utilises semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. Both are prescription-only medicines that require clinical assessment and work alongside lifestyle modifications. Wegovy follows a five-dose escalation schedule (0.25mg to 2.4mg maintenance), whilst Mounjaro progresses through six dose levels (2.5mg to 15mg maintenance). EverydayMeds stocks both medications, allowing your prescriber to recommend the most appropriate option for your individual circumstances.
Wegovy vs Mounjaro Pricing and Value Comparison
EverydayMeds offers transparent pricing for both Wegovy and Mounjaro weight management options. Wegovy starts at £79.99 for the 0.25mg starter dose (weeks 1-4) with new customer code FIRST40, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing your first two months of treatment. Returning customers benefit from code DOSE25 at checkout.
Mounjaro pricing follows a different structure reflecting its unique dosing schedule and dual-hormone mechanism. Both medications represent significant investments in long-term weight management, and EverydayMeds provides flexible bundle options to support consistent treatment. The Consistency bundles offer two pens of the same dose for patients requiring extended time at a particular level, whilst our Step-Up bundles provide seamless dose progression. Your 3-minute online clinical assessment will help determine which medication and dosing approach aligns with your weight management goals and budget considerations.
Clinical Evidence Supporting Wegovy vs Wegovy for weight management Discussions
The STEP clinical trial programme provides robust evidence for Wegovy's weight management efficacy. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 2 demonstrated approximately clinically studied weight loss in patients with type 2 diabetes, whilst STEP 3 showed approximately clinically studied weight loss with intensive behavioural therapy support.
The recent SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events (HR 0.80) among patients online pharmacy with semaglutide. Mounjaro's SURMOUNT trial programme has shown significant weight management results with tirzepatide's dual-hormone approach. However, these trials used different methodologies, patient populations, and endpoints, making direct percentage comparisons inappropriate. Both medications demonstrate substantial potential for supporting weight management when used alongside appropriate lifestyle modifications.
How Wegovy Works in Your Weight Management Journey
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a naturally occurring hormone that regulates appetite and food intake. This mechanism helps reduce hunger signals sent to your brain whilst promoting feelings of fullness after smaller meals. The medication may also influence food cravings by acting on appetite control centres in your brain, potentially making it easier to adhere to a reduced-calorie diet. Wegovy is administered once weekly via a pre-filled FlexTouch pen, offering convenient subcutaneous injection typically in the thigh, abdomen, or upper arm. The gradual dose escalation over 16 weeks helps your body adjust to the medication whilst minimising potential gastrointestinal side effects commonly experienced during the initial treatment period.
EverydayMeds Ordering Process for Weight Loss Medications
Starting your weight management journey with EverydayMeds begins with our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight management goals, and any contraindications. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service) to determine your suitability for Wegovy, Mounjaro, or alternative treatments. Once approved, your prescription-only medicine is prepared by our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery using specialist cold-chain packaging to maintain the required 2-8°C temperature range. You'll receive tracking information and temperature monitoring confirmation to ensure your medication arrives in optimal condition. Our clinical team remains available for ongoing support throughout your treatment journey, including dose escalation guidance and side effect management advice.
Storage Advantages: Wegovy vs Mounjaro for Practical Use
Wegovy offers superior storage flexibility compared to Mounjaro, particularly beneficial for patients with active lifestyles or frequent travel commitments. Once removed from refrigeration, Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks, compared to Mounjaro's 21-day room temperature limit. Both medications must be stored in the refrigerator at 2-8°C before first use and protected from light in their original packaging. The FlexTouch pen design provides intuitive dose selection and injection, with dose escalation occurring every 4 weeks according to your prescribed schedule. Proper storage is crucial for maintaining medication effectiveness, and EverydayMeds provides comprehensive storage guidance with every order. The extended room temperature stability makes Wegovy particularly suitable for patients who travel frequently for work or leisure activities.
Wegovy vs Ozempic Weight Management: Why Licensed Indication Matters
Understanding the regulatory distinction between Wegovy vs Wegovy for weight management is essential for safe and legal treatment. The MHRA has specifically licensed Wegovy for weight management based on comprehensive clinical trial data demonstrating its safety and efficacy in this indication. Ozempic, whilst containing the same active ingredient (semaglutide), is licensed only for type 2 diabetes management and carries different dosing, monitoring, and safety considerations. NICE guidance TA875 specifically recommends Wegovy for weight management with specialist support, acknowledging its role in comprehensive obesity treatment programmes.
This regulatory framework ensures that patients receive appropriate clinical oversight, proper dose escalation, and suitable monitoring for weight management rather than diabetes care. EverydayMeds adheres strictly to these licensing requirements, ensuring that our weight management services comply with MHRA regulations and GPhC professional standards. Our prescribers evaluate each patient's suitability based on weight management criteria, including BMI thresholds and weight-related comorbidities, rather than diabetes management considerations that would apply to Ozempic prescribing.
Start Your Wegovy vs Mounjaro Comparison Today
Both Wegovy and Mounjaro are available through EverydayMeds' comprehensive weight management service, with your prescriber determining which option best suits your individual needs and circumstances. New customers can use code FIRST40 at checkout, whilst returning customers benefit from DOSE25 for ongoing treatment costs. Our clinical assessment evaluates your medical history, weight management goals, and lifestyle factors to recommend the most appropriate medication and dosing schedule. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your assessment today, with next-day delivery available once your prescription is approved. Your weight management journey deserves expert pharmaceutical support from a trusted GPhC-registered provider committed to your long-term success.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
